Directors and Company Secretary
LiDCO Group Plc Directors
Matthew Sassone – Chief Executive Officer
Mr Sassone was appointed to the Board on 15 June 2015 and took over the role of Chief Executive Officer on the retirement of Dr Terry O’Brien on 14 August 2015. He has over 19 years’ experience in the medical industry having started his career in sales for Quintiles in 1996. He spent 12 years at Smiths Medical in various sales, marketing and business development roles achieving the role of Managing Director, Northern and Eastern Europe and Russia in 2010. In 2012 he moved to ArjoHuntleigh, a division of the Getinge Group, as Senior Vice President Global Marketing and was subsequently appointed Chief Marketing Officer of Maquet, also a division of Getinge. Mr Sassone has a degree in biochemistry with microbiology. Mr Sassone is a member of the Group’s Nomination Committee.
Tim Hall – Chief Financial Officer
Tim Hall joined the Board on 11 March 2019 as Chief Financial Officer and Company Secretary. Tim is a Chartered Accountant with almost 30 years’ experience in financial roles in the life science industry.
Prior to joining LiDCO, Tim was Chief Financial Officer of Oxford Gene Technology IP Ltd (“OGT”) from 2012 to 2018 during which time he helped to grow the business substantially through both geographic expansion and M&A activity before its successful sale to Sysmex Corporation in 2017. Before moving to OGT, Tim was Finance Director at AIM-listed Lombard Medical Technologies PLC for six years and previously had senior finance roles in UCB S.A, Celltech Group plc and Medeva PLC. Tim’s early career included finance and project management roles at Glaxo Wellcome plc/Wellcome plc. Tim qualified as a Chartered Accountant with Touche Ross & Co, now Deloitte.
Tim Hall – Company Secretary